Status:
COMPLETED
Low Calorie Diet or VLCKD Combined With Physical Training for Preserving Muscle Mass During Weight Loss in Sarcopenic Obesity
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Sarcopenic Obesity
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
The prevalence of sarcopenic obesity (SO) is increasing worldwide, posing important challenges to public health and national health care system, especially during the COVID pandemic. In subjects with ...
Eligibility Criteria
Inclusion
- obesity (BMI 30-40)
- FAT MASS % ( \> 41% for W, \>29% for M)
- HOMA-IR \> 2,5
Exclusion
- known hypersensitivity to one or more components used in the protocol products; history of renal, cardiac or cerebrovascular diseases; psychiatric disturbances; hydroelectrolytic alterations, diagnosis of type 1 diabetes lack of informed consent; history of or planned weight loss surgery
Key Trial Info
Start Date :
January 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 4 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05287659
Start Date
January 3 2022
End Date
March 4 2022
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sapienza University of Rome
Roma, RM, Italy, 00161